Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Sebia and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Sebia is a global leader in specialized in-vitro diagnostics (IVD), specifically renowned for its pioneering work in clinical protein electrophoresis. The company provides advanced equipment and reagents used for the screening and monitoring of various diseases, with a primary focus on oncology (notably Multiple Myeloma), metabolic disorders (diabetes), hemoglobinopathies, and autoimmune/infectious diseases. Headquartered in Lisses, France, Sebia operates globally across more than 120 countries. The company has significantly expanded its diagnostic portfolio and capabilities through strategic acquisitions, including ORGENTEC Diagnostika, Corgenix, Arotec, and Zeus Scientific, allowing it to integrate autoimmunity and infectious disease testing into its core electrophoresis-based offerings.
CLASSIFICATION
Company Type:Diagnostics
Industry:Medical Devices
Sub-Industry:In Vitro Diagnostics (IVD)
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$200M-$500M
Founded:1967
Ownership:private
Status:operating
FUNDING
Stage:Private Equity Backed
Investors:CVC Capital Partners, Tethys Invest, Caisse de dépôt et placement du Québec (CDPQ), Warburg Pincus
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A
Modalities:Capillary Electrophoresis, Gel Electrophoresis, IFA, ELISA
Active Trials:0
Trial Phases:-
CORPORATE STRUCTURE
Subsidiaries:ORGENTEC Diagnostika, Corgenix Medical Corporation, AROTEC Diagnostics Limited, Zeus Scientific
Key Partnerships:Janssen Biotech (collaboration for multiple myeloma tests)
COMPETITION
Position:Leader
Competitors:Qiagen, Enzo Biochem, Sino Biological
LEADERSHIP
Key Executives:
Jean-Marc Chermette - President and CEO
Arnaud Collin - Group Vice President Global Regulatory Affairs & Quality
LINKS
Website:sebia.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Sebia. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.